Skip to main content
. 2023 Jul 25;77(Suppl 2):S125–S133. doi: 10.1093/cid/ciad326

Table 1.

Trial Site's Main Characteristics

Country Setting and Sites Expected Antibiotic Prescription Rate (Based on Historic Prescribing) Malaria Endemicity and Transmission
Patterns
Projected Total Sample Size Over 12 ma Study Population
Burkina Faso Rural
Pella and Temnaore health centers
77% Seasonal: high transmission: June to July and October to November 1718 Children and adolescents (6 m to <18 y)
Ghana Urban, semi-urban
Shai-Osudoku District hospital,
St. Andrew's Catholic hospital,
Pramram District hospital and Ningo health center
43% Seasonal: July to Octoberb 2766 Children and adolescents (6 m to <18 y)
Uganda Rural
Aduku level IV health center,
Nagongera level IV health center
Kihihi level IV health center
73% High, low, and moderate malaria transmission depending on the sitec 2400 Children (>1 y), Adolescents, adults

Both arms, including losses to follow-up.

Malaria season typically runs March to October but varies between ecological seasons. In the Shai-Osudoku area where the study was conducted, the seasons run from May to June and September to November.

Please see the Uganda clinical trial manuscript later in the Supplement for further information (Kapisi J, et al, CID Supplement 2023).